John Miller, Ph.D.

John Miller, Ph.D., is the Vice President, Head of Biology at Rectify. He comes to the role with over 12 years of experience in biotechnology. John most recently served as Senior Director, Discovery at CAMP4 Therapeutics Corporation, and before that led discovery biology teams and efforts at Vesalius Therapeutics and Ohana Biosciences. Prior to these, he spent nearly a decade at Proteostasis Therapeutics, working on the discovery and characterization of the company’s cystic fibrosis modulators from their initial identification through their phase 2 clinical studies. Along the way, John made substantial contributions to the company’s initial public offering and regulatory filings, as well as overseeing the successful elucidation and publication of the mechanism of action of the novel amplifier class of CFTR modulators. John received postdoctoral training at the Buck Institute for Research in Aging and obtained his Ph.D. in genetics from the University of Washington and his B.S. in biochemistry from Colorado State University.